CENTER FOR INTEGRATED HEALING CHANGES NAME.

.
Welcome - A New Name, New Identity & Ten Year Anniversary
The Centre for Integrated Healing has a new name - InspireHealth. Our new identity reflects our vision and belief that personal empowerment and engagement in health through nutrition, exercise and emotional and spiritual support are vitally important foundations to optimal cancer care, prevention, health and healing.
.
With 10 years of experience, our programs have become the new standard in integrative cancer care – at the forefront of a patient-driven movement to engage in health while undergoing cancer treatment. Our physicians guide patients in optimally supporting their health and creating a personalized cancer care plan integrated with their conventional treatments. This integrative approach, which engages mind, body and spirit, optimally supports health and there is growing evidence that it is of vital importance in the treatment of cancer.
.
Check them out at www.inspirehealth.ca.

A Diet to Protect Against Cancer

.
A healthy diet can help the body in its efforts to heal itself, and in some cases, particular foods can strengthen the immune system and lessen the risks of serious illness. To help reduce your risk of some types of cancer, try the following:
.
Avoid polyunsaturated vegetable oils, margarine, vegetable shortening, all partially hydrogenated oils, and all foods that might contain trans-fatty acids (such as deep-fried foods).
Increase omega-3 fatty acids by eating more cold water oily fish, freshly ground flaxseeds, and walnuts.
Reduce consumption of animal foods and try to replace them with vegetable proteins such as whole soy products.
Use hormone-free, organically produced products whenever possible.
Eat plenty of fresh fruits and vegetables.
Eat shiitake, enokidake, maitake, and oyster mushrooms frequently.
Drink green tea daily.
.
from....Dr. Weil website

PROMISING CANCER RESEARCH.

A new class of compounds developed by two university of Kentucky researchers shows promise as a nontoxic treatment of some cancers previously treated with toxic chemotherapy.

In a study published in the academic journal Chemistry and Biology, researchers describe a compound that acts directly on LMP2, a component of the immune proteasome variant that has been identified as abundantly expressed in certain types of tumours, including some prostate cancers.

The compound dubbed UK-101, inhibits LMP2 while not attacking normal cells, indicating that it could be an effective cancer treatment that does not produce the kinds of unpleasant side effects repoted by many patients currently treated with broadly acting proteasome inhibitors and chemotherapeutics.